iTech Medical receives Health Canada approval for Muscle Pattern Recognition System

NewsGuard 100/100 Score

iTech Medical, Inc. (OTCBB:IMSU)(FWB:0IM), a medical information technology company, announced today that it has received Health Canada approval for the Company's Muscle Pattern Recognition (MPR) System, a non-invasive clinical assessment tool being developed to assist in the diagnosis and treatment of back and neck pain, one of the most common chronic conditions in Canada.

"The approval of the MPR System by Health Canada is a significant achievement for iTech Medical and represents another major step towards the global commercialization of the device," stated Wayne Cockburn, President & CEO at iTech Medical. "Diagnosing and treating neck and back pain is one of the most expensive healthcare problems in Canada. It is estimated that 30% to 40% of all workplace absences are due to this condition. The cause of neck and back pain is not always apparent and in fact, in approximately 85% to 90% of individuals with neck and back pain, no specific cause can be identified. We believe our MPR System can play an important role in helping to identify the source of these problems and provide the healthcare system a new tool to not only assist in the diagnosis and treatment of the underlying conditions, but to help reduce related medical costs and improve patient outcomes."

"We believe that patients, physicians and insurance providers stand to benefit from our Muscle Pattern Recognition (MPR) technology," said Karl Wolcott, VP of Sales and Marketing for iTech Medical. "We are in discussions with potential strategic channel partners in Canada to evaluate the landscape and begin aggressively marketing the MPR technology in Canada."

Source:

iTech Medical, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Does diabetes increase the risk of long COVID?